Clincosm

Accelerating important medicines

[Clincosm @clincosm]

Do you use https://t.co/JTApThcF9l? If so, we would love your input on this very quick survey.
#clinicaltrials #clinicalresearch
https://t.co/hYp29ziIGW

[Clincosm @clincosm]

Clincosm has a new phone number! See our latest blog post.
https://t.co/irqYcuqPnD

[Clincosm @clincosm]

Check out the latest blog post from our CEO on why improving search is a first priority!
#clinicaltrials
https://t.co/cIzMX7iW2L

[Clincosm @clincosm]

Welcome to the Clincosm blog!
https://t.co/ANI6Xjinwt
#clinicaltrials #ClinicalResearch

[Clincosm @clincosm]

Can tocilizumab reduce COVID-19 mortality after all? Is it a case of Goldilocks timing?
#clinicaltrials #ClinicalResearch
https://t.co/v6YxI91kN0

[Clincosm @clincosm]

Possible method to prevent cancer? Initial phase I trial of this breast cancer vaccine (https://t.co/0do3HfoaKk) will look at early treatment in triple negative breast cancer but preclinical studies suggest it might be useful in the future as primary prevention. #clinicaltrials

[Clincosm @clincosm]

Another mRNA vaccine, another EUA likely. The VRBPAC voted today to recommend Emergency Use Authorization for Moderna's COVID-19 vaccine. Here's the data for that meeting:
#clinicaltrials #clinicalresearch
https://t.co/TGP4jbXCzy

[Clincosm @clincosm]

The Data - Pfizer/BioNTech vaccine
#clinicaltrials #vaccine #COVID19
https://t.co/LJRXM1e71K

[Clincosm @clincosm]

Collaboration is key to solving big problems faster. Just look at COVID-19 vaccines.

[Clincosm @clincosm]

A way to improve efficiency and be more patient friendly

[Nature Medicine @NatureMedicine]

Will patient-centric #sampling become the norm for #clinicaltrials after COVID-19? The pandemic has propelled this approach to the mainstream and innovation to improve patient sampling could ameliorate efficiency, say experts https://t.co/5dexHAMV0J

[Clincosm @clincosm]

Should peer reviews be public?
(even for rejected papers)
Will this become scientific publication standard?
#clinicaltrials #clinicaltrial #medicines
https://t.co/oukVQAeTzB

[Clincosm @clincosm]

More on this debate: https://t.co/cXSR14zXdI

[Clincosm @clincosm]

Do you agree? When is the ethical time to unblind and vaccinate placebo recipients?
#clinicaltrials #clinicalresearch #medicine
https://t.co/JBSndtBW5L

[Clincosm @clincosm]

What drugs in preclinical studies are you most looking forward to seeing in clinical trials?
#medicine #clinicaltrials #clinicalresearch
https://t.co/WxO4uaaUlH

[Clincosm @clincosm]

Stratification and permuted blocks are typically used with relatively small sample sizes. This interview discusses benefits and problems associated with these techniques and touches on drawing causality conclusions from observational data.
https://t.co/bTQkxItZJm

[Clincosm @clincosm]

Clinical trials are expensive and there's no guarantee results will be favorable but the hope, opportunity and potential impact on human lives can be tremendous. (Gene therapy for this condition is in Phase I/II trials https://t.co/YUZu3E4JOJ)
https://t.co/K5Vlr7SRLe

[Clincosm @clincosm]

Eligibility criteria and enrollment for clinical trials should better reflect the age and health status of the patients expected to receive the treatments once approved so that the results of the studies are valid for these populations. https://t.co/qj9ENfxA3t

[National Cancer Institute @theNCI]

People with prostate or kidney cancer that has not responded to standard treatments may be eligible to join a clinical trial at the NIH Clinical Center: https://t.co/0mQtVYCfCn @NCIResearchCtr @gulleyj1 #prostatecancer #kidneycancer